No Data
Express News | Beijing Tiantan Biological Products Corporation: The holding subsidiary Chengdu Rongs生 has obtained the Turkish GMP certificate.
Beijing Tiantan Biological Products' 2024 Profit Jumps 39%; Shares Soar 8%
Beijing Tiantan Biological Products Corporation (600161): The advantages of plasma sources are gradually being unleashed, and the operational performance is growing rapidly.
Performance Review: On January 20, 2025, the company released its preliminary performance report for 2024, expecting to achieve revenue of 6.034 billion yuan, a year-on-year increase of +16%; it is expected to achieve a Net income of 15.47.
Tiantan Biotech: Tiantan Biotech 2024 Annual Performance Report Announcement
Tiantan Biotech 2024 Annual Results Report Announcement
Express News | Beijing Tiantan Biological Products Corporation: In 2024, net income increased by 39.42% year-on-year.